首页> Clinical colorectal cancer> A Phase I/II Study of Capecitabine Given on a Week on/Week off Schedule Combined With Bevacizumab and Oxaliplatin for Patients With Untreated Advanced Colorectal Cancer.

A Phase I/II Study of Capecitabine Given on a Week on/Week off Schedule Combined With Bevacizumab and Oxaliplatin for Patients With Untreated Advanced Colorectal Cancer.

导出原文传递

翻译打印收藏纠错

第一作者： Sehgal R

作者： Sehgal R ^[1] ; Lembersky BC ; Rajasenan KK ; Crandall TL ; Balaban EP ; Pinkerton RA ; Kane P ; Schmotzer A ; Zeh H ; Potter DM ; Ramanathan RK

作者单位： University of Pittsburgh Cancer Institute, Pittsburgh, PA. ^[1]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical colorectal cancer

2011年10卷2期

117-120页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Clinical colorectal cancer

2011年10卷2期

117-120页

检索历史清除

A Phase I/II Study of Capecitabine Given on a Week on/Week off Schedule Combined With Bevacizumab and Oxaliplatin for Patients With Untreated Advanced Colorectal Cancer.

Clinical colorectal cancer

相似文献

同项目论文

Clinical colorectal cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Phase I/II Study of Capecitabine Given on a Week on/Week off Schedule Combined With Bevacizumab and Oxaliplatin for Patients With Untreated Advanced Colorectal Cancer.

Clinical colorectal cancer

相似文献

同项目论文

Clinical colorectal cancer

相关期刊

检索历史清除